drugset / Trial / NCT00916578

Xeloda (Capecitabine) and External Beam Radiation

NCT00916578 ↗

Phase 2 Completed 33 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to find out if Xeloda® (capecitabine) and radiation therapy can help to control breast cancer that did not respond well to chemotherapy. The safety of this study treatment will also be studied.

Timeline

Start
2009-06-05
Primary completion
2017-06-06
Completion
2017-06-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 825 mg/m2 Oral

Indications